Beth Chasen
Impact in
Papers in
- Neurology 13
- Neuroblastoma Research and Treatments 13
- Epidemiology 12
- Neuroendocrine Tumor Research Advances 11
- Co-authors
- Philippe Ruszniewski (9 shared papers)Timothy J. Hobday (10 shared papers)Maribel Lopera Sierra (8 shared papers)Edward M. Wolin (10 shared papers)David Bushnell (10 shared papers)Richard P. Baum (7 shared papers)Andrew Hendifar (6 shared papers)Matthew H. Kulke (6 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancers (2 papers)Neuroendocrinology (2 papers)Annals of Oncology (2 papers)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Beth Chasen
19 papers receiving 552 citations
Hit Papers
Peers
Comparison fields: 5 of 55
- Neurology 261
- Oncology 343
- Epidemiology 369
- Radiology, Nuclear Medicine and Imaging 122
- Emergency Medical Services 27
Countries citing papers authored by Beth Chasen
This map shows the geographic impact of Beth Chasen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Chasen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Chasen more than expected).
Fields of papers citing papers by Beth Chasen
This network shows the impact of papers produced by Beth Chasen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Chasen. The network helps show where Beth Chasen may publish in the future.
Co-authors
The 25 scholars most cited alongside Beth Chasen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial Hit paper breakdown → | 2018 | 272 |
| 2 | 2019 | 55 | |
| 3 | 2016 | 45 | |
| 4 | 2015 | 38 | |
| 5 | 2021 | 30 | |
| 6 | 2011 | 29 | |
| 7 | NETTER-1 Phase III in Patients With Midgut Neuroendocrine Tumors Treated With 177Lu-DOTATATE: Efficacy and Safety Results. | 2016 | 19 |
| 8 | 2018 | 15 | |
| 9 | 2019 | 14 | |
| 10 | 2021 | 10 | |
| 11 | 2016 | 10 | |
| 12 | 2017 | 4 | |
| 13 | 2016 | 4 | |
| 14 | QOL Improvements in NETTER-1 Phase III Trial in Patients With Progressive Midgut Neuroendocrine Tumors | 2018 | 3 |
| 15 | 2017 | 3 | |
| 16 | NETTER-1 Phase III Trial : Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors | 2017 | 2 |
| 17 | 2016 | 2 | |
| 18 | Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients | 2020 | 1 |
| 19 | 2018 | 1 |
About Beth Chasen
Beth Chasen is a scholar working on Neurology, Epidemiology, Oncology, Surgery and Obstetrics and Gynecology, having authored 19 papers that have together received 557 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (13 papers), Neuroendocrine Tumor Research Advances (11 papers), Lung Cancer Research Studies (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Gestational Trophoblastic Disease Studies (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Uterine Myomas and Treatments (2 papers). The work is most often cited by research in Neurology (261 citations), Oncology (343 citations), Epidemiology (369 citations), Radiology, Nuclear Medicine and Imaging (122 citations) and Emergency Medical Services (27 citations). Beth Chasen has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Philippe Ruszniewski, Timothy J. Hobday, Maribel Lopera Sierra, Edward M. Wolin, David Bushnell, Richard P. Baum, Andrew Hendifar, Matthew H. Kulke, Jonathan Strosberg and William D. Erwin. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Neuroendocrinology, Annals of Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.